Vandana Singh | January 24, 2025
On Friday, Moderna, Inc. (NASDAQ:MRNA) was awarded a tender to supply its mRNA COVID-19 vaccine in the European Union (EU). What Happened: Seventeen participating countries—including Norway and North Macedonia—can access Moderna’s mRNA COVID-19 vaccine. “Diversity of supply and availability of vaccine formats such as prefilled syringes are vital to help increase vaccination rates and enhance vaccination campaign […]
Vandana Singh | December 11, 2024
On Wednesday, Candel Therapeutics, Inc. (NASDAQ:CADL) announced results from a phase 3 trial of CAN-2409 viral immunotherapy in intermediate-to-high-risk, localized prostate cancer patients. The trial met its primary endpoint and demonstrated statistically significant improvement in disease-free survival in patients who received CAN-2409 plus the prodrug (valacyclovir) combined with the standard of care compared to the […]
Vandana Singh | October 2, 2024
On Wednesday, Eli Lilly And Co. (NYSE:LLY) announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development. As the company inches closer to becoming the first pharma company in the $1 trillion club, it aims to strengthen its standing as one of the top 10 most valuable […]
Vandana Singh | July 11, 2024
Biodexa Pharmaceuticals PLC (NASDAQ:BDRX) announced progress on eRapa, its drug to treat Familial Adenomatous Polyposis (FAP), an inherited disorder characterized by cancer of the large intestine (colon) and rectum. 12-month data from a phase 2 clinical trial were recently presented at the 2024 InSIGHT biannual meeting. With FAP, hundreds or thousands of precancerous polyps grow throughout […]
Vandana Singh | April 3, 2024
Tuesday, the FDA approved Vanda Pharmaceuticals Inc’s (NASDAQ:VNDA) Fanapt (iloperidone) tablets for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults. Fanapt is an atypical antipsychotic agent that has been used for the acute treatment of patients with schizophrenia since its FDA approval in 2009. Bipolar disorder is a psychiatric chronic condition […]
Always be feeding your money brain. Claim one or all of the FREE offers from some of our partners below.